WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004007430) BENZAMIDE OR PHENYLACETAMIDE DERIVATIVES USEFUL AS THYROID RECEPTOR LIGANDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/007430    International Application No.:    PCT/EP2003/007333
Publication Date: 22.01.2004 International Filing Date: 08.07.2003
Chapter 2 Demand Filed:    02.02.2004    
IPC:
A61K 31/195 (2006.01), A61P 5/16 (2006.01), C07C 235/34 (2006.01), C07C 235/52 (2006.01)
Applicants: KARO BIO AB [SE/SE]; Novum, S-141 57 Huddinge (SE) (For All Designated States Except US).
BRISTOL-MYERS SQUIBB COMPANY [US/US]; P.O. Box 4000, Princeton, NJ 08543-4000 (US) (For All Designated States Except US).
GARG, Neeraj [SE/SE]; (SE) (For US Only).
GADIM, Mahmoud, Rahimi [SE/SE]; (SE) (For US Only).
ERICSSON, Thomas, Anders, Wilson [SE/SE]; (SE) (For US Only).
MALM, Lars, Johan [SE/SE]; (SE) (For US Only).
RYONO, Denis, Evan [US/US]; (US) (For US Only)
Inventors: GARG, Neeraj; (SE).
GADIM, Mahmoud, Rahimi; (SE).
ERICSSON, Thomas, Anders, Wilson; (SE).
MALM, Lars, Johan; (SE).
RYONO, Denis, Evan; (US)
Agent: BANNERMAN, David, Gardner; Withers & Rogers, Goldings House, 2 Hays Lane, London SE1 2HW (GB)
Priority Data:
0215978.8 10.07.2002 GB
Title (EN) BENZAMIDE OR PHENYLACETAMIDE DERIVATIVES USEFUL AS THYROID RECEPTOR LIGANDS
(FR) NOUVEAUX COMPOSES
Abstract: front page image
(EN)This invention relates to novel compounds, which are thyroid receptor ligands, and to methods of preparing such compounds. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolism dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described herein is administered in a therapeutically effective amount.
(FR)La présente invention concerne de nouveaux composés, qui sont des ligands de récepteurs de la thyroïde et des techniques de préparation de ces composés. Cette invention concerne aussi une technique de prévention, d'inhibition ou de traitement de maladies ou de pathologies associées à un dysfonctionnement du métabolisme ou dépendantes de l'expression d'un gène régulé T3, un composé de cette invention étant administré en quantité thérapeutiquement efficace.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)